S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
S&P 500   5,051.41 (-0.21%)
DOW   37,798.97 (+0.17%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
Free Trial
CVE:THCX

Hydropothecary (THCX) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free THCX Stock Alerts
C$5.30
+0.33 (+6.64%)
(As of 06/21/2018)
Compare
Today's Range
C$5.00
▼
C$5.37
50-Day Range
C$5.30
▼
C$5.30
52-Week Range
C$1.10
▼
C$5.42
Volume
5.38 million shs
Average Volume
2.35 million shs
Market Capitalization
C$949.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
THCX stock logo

About Hydropothecary Stock (CVE:THCX)

The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.

THCX Stock Price History

THCX Stock News Headlines

April 16, 2023 | finance.yahoo.com
AXS CANNABIS ETF ESTIMATED CASH (^THCX-EU)
February 25, 2023 | uk.finance.yahoo.com
The Hydropothecary Corporation (HEXO.TO)
April 16, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
February 17, 2023 | finance.yahoo.com
AXS Cannabis ETF (THCX)
August 16, 2022 | prnewswire.com
Outlook on the Medical Cannabis Global Market to 2027 - Emergence of Cannabis Legalization Presents Opportunities USA - English - USA - English - PR Newswire
August 15, 2022 | businesswire.com
The Worldwide Medical Cannabis Industry is Expected to Reach $24.8 Billion by 2027 - ResearchAndMarkets.com - Business Wire
August 3, 2021 | gurufocus.com
Bedel Financial Consulting, Inc. Buys Innovator S&P 500 Power Buffer ETF - GuruFocus.com
August 2, 2021 | gurufocus.com
Optimum Investment Advisors Bu - GuruFocus.com
April 16, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
July 30, 2021 | markets.businessinsider.com
The Week In Cannabis: Tilray's Huge Week, Colin Hanks, Allen Iverson, Seth Rogen And More - Markets Insider
July 30, 2021 | gurufocus.com
Baldwin Brothers Inc Buys Marr - GuruFocus.com
See More Headlines
Receive THCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hydropothecary and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:THCX
CUSIP
N/A
CIK
N/A
Web
www.thehydropothecary.com
Phone
+1-416-7504949
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
179,077,000
Free Float
N/A
Market Cap
C$949.11 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Sebastien G. St-Louis (Age 34)
    Co-Founder, Pres, CEO & Director
  • Mr. Adam Miron (Age 34)
    Co-founder, Chief Brand Officer & Director
  • Mr. Ed Chaplin (Age 48)
    CFO & Corp. Sec.
  • Mr. James McMillan (Age 50)
    VP of Bus. Devel.
  • Mr. Arno Groll
    Director of Operations

Key Competitors

View All Competitors

THCX Stock Analysis - Frequently Asked Questions

How have THCX shares performed in 2024?

Hydropothecary's stock was trading at C$5.30 on January 1st, 2024. Since then, THCX stock has increased by 0.0% and is now trading at C$5.30.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Hydropothecary own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hydropothecary investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Cronos Group (CRON), CannTrust (CTST), Funko (FNKO), Riot Platforms (RIOT) and Unrivaled Brands (TRTC).

How do I buy shares of Hydropothecary?

Shares of THCX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:THCX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends